09/21/2023 | Sponsored by Glaukos | 4 min read
Glaukos’ technology and products continue to transform the way ophthalmic surgeons manage chronic eye diseases
09/20/2023 | Anat Loewenstein | 7 min read
Addressing the unmet visual acuity needs of neovascular AMD patients
09/18/2023 | Alun Evans | 2 min read
Will AI be the future of retinopathy of prematurity detection?
09/13/2023 | Mark A. Bullimore | 4 min read
An open letter to The Ophthalmologist
09/12/2023 | Alun Evans | 2 min read
Innovative technique for predicting chronic cerebral hypoperfusion
08/30/2023 | Oscelle Boye | 7 min read
Sitting Down With… Sascha Fauser, Global Head of Ophthalmology, Pharma Research and Early Development (pRED) Vice President, Roche
08/23/2023 | 3 min read
If the drop first regimen isn’t working – what comes next?
08/22/2023 | Alun Evans | 6 min read
The biotech company taking anti-VEGF therapies to the next level
08/21/2023 | Alun Evans | 2 min read
How do retinal disease patients perceive AI-driven technology?
08/07/2023 | Sarah Healey | 6 min read
FDA approve new treatment for geographic atrophy
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: